IN2014DN07325A - - Google Patents

Info

Publication number
IN2014DN07325A
IN2014DN07325A IN7325DEN2014A IN2014DN07325A IN 2014DN07325 A IN2014DN07325 A IN 2014DN07325A IN 7325DEN2014 A IN7325DEN2014 A IN 7325DEN2014A IN 2014DN07325 A IN2014DN07325 A IN 2014DN07325A
Authority
IN
India
Prior art keywords
roflumilast
preparation
provides
vic
synthesis
Prior art date
Application number
Other languages
English (en)
Inventor
yi jing Chen
Stanislaw Pikul
Shen Chun Kuo
Guo Dong Chu
Original Assignee
Scinopharm Changshu Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Changshu Pharmaceuticals Ltd filed Critical Scinopharm Changshu Pharmaceuticals Ltd
Publication of IN2014DN07325A publication Critical patent/IN2014DN07325A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/307Compounds having groups having acetal carbon atoms bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN7325DEN2014 2012-03-07 2013-03-07 IN2014DN07325A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2012/072020 WO2013131255A1 (en) 2012-03-07 2012-03-07 Preparation method of roflumilast
PCT/CN2013/072286 WO2013131484A1 (en) 2012-03-07 2013-03-07 Process for preparation of roflumilast

Publications (1)

Publication Number Publication Date
IN2014DN07325A true IN2014DN07325A (pl) 2015-04-24

Family

ID=49115870

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7325DEN2014 IN2014DN07325A (pl) 2012-03-07 2013-03-07

Country Status (13)

Country Link
US (2) US9085533B2 (pl)
EP (1) EP2822929B1 (pl)
JP (1) JP6122042B2 (pl)
KR (1) KR101680182B1 (pl)
AU (1) AU2013230356B2 (pl)
BR (1) BR112014022074A2 (pl)
CA (1) CA2865539C (pl)
ES (1) ES2640470T3 (pl)
IL (1) IL234366A (pl)
IN (1) IN2014DN07325A (pl)
NZ (1) NZ629161A (pl)
TW (1) TWI460163B (pl)
WO (2) WO2013131255A1 (pl)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114114C (en) 1992-06-15 2005-05-03 Nigel Robert Arnold Beeley Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
IL106517A0 (en) 1992-07-28 1994-08-26 Rhone Poulenc Rorer Ltd Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
US5712298A (en) 1993-07-02 1998-01-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
JPH07316054A (ja) * 1993-09-06 1995-12-05 Ishihara Sangyo Kaisha Ltd ピリダジノン誘導体またはその塩、それらの製造方法およびそれらを含有する抗ショック剤
WO2001090076A1 (en) 2000-05-25 2001-11-29 Merck Frosst Canada & Co. Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
WO2002096921A1 (fr) * 2001-05-30 2002-12-05 Nisshin Seifun Group Inc. Nouveau derive glucose induisant l'apoptose, procede de production et utilisation comme medicament
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
KR101179012B1 (ko) * 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
BRPI0415753A (pt) * 2003-10-21 2006-12-19 Pharmacia Corp método para tratamento e prevenção da inflamação respiratória com um inibidor de ciclooxigenase-2 em associação com um inibidor de fosfodiesterase 4 e composições que os contêm
JP4996834B2 (ja) * 2005-07-06 2012-08-08 高砂香料工業株式会社 バニリンアセタール類およびそれを含有する感覚刺激剤組成物
WO2008006509A1 (en) 2006-07-14 2008-01-17 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
EP1975166A1 (en) * 2007-03-30 2008-10-01 Bayer Schering Pharma AG Synthesis of anthranilamides
CN102336703B (zh) * 2011-07-20 2013-09-25 华润赛科药业有限责任公司 一种制备罗氟司特的方法
CN102351787B (zh) * 2011-08-18 2014-08-13 天津市汉康医药生物技术有限公司 高生物利用度的罗氟司特化合物

Also Published As

Publication number Publication date
KR20140138879A (ko) 2014-12-04
KR101680182B1 (ko) 2016-11-28
WO2013131484A1 (en) 2013-09-12
AU2013230356B2 (en) 2016-12-22
US20150274667A1 (en) 2015-10-01
US20150025246A1 (en) 2015-01-22
JP6122042B2 (ja) 2017-04-26
EP2822929A4 (en) 2016-01-13
CA2865539C (en) 2016-08-23
WO2013131255A1 (en) 2013-09-12
US9233925B2 (en) 2016-01-12
TWI460163B (zh) 2014-11-11
BR112014022074A2 (pt) 2018-05-22
JP2015510869A (ja) 2015-04-13
TW201341362A (zh) 2013-10-16
IL234366A (en) 2016-12-29
EP2822929B1 (en) 2017-06-14
CA2865539A1 (en) 2013-09-12
AU2013230356A1 (en) 2014-09-25
EP2822929A1 (en) 2015-01-14
US9085533B2 (en) 2015-07-21
NZ629161A (en) 2015-08-28
ES2640470T3 (es) 2017-11-03

Similar Documents

Publication Publication Date Title
PH12014500987A1 (en) Neprilysin inhibitors
MY163394A (en) Substituted aminobutyric derivates as neprilysin inhibitors
TN2013000362A1 (en) Benzodioxane inhibitors of leukotriene production
PH12015502056A1 (en) Benzothiazole compounds and their pharmaceutical use
EA201491824A1 (ru) Производные бензамида для ингибирования активности abl1, abl2 и bcr-abl1
MY172924A (en) Neprilysin inhibitors
GEP20217235B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
PH12014502586A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
IN2015DN01119A (pl)
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
BR112014005554A2 (pt) aminas de imidazol como moduladores de atividade de quinase
PH12013501859A1 (en) Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
WO2013093931A3 (en) Novel prodrugs of phenolic drugs
PH12014502285A1 (en) Anti-malarial agents
IN2013DN02555A (pl)
PH12012000124A1 (en) Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride and pharmaceutical compositions containing it
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.
PH12013500051A1 (en) Crystalline form of a 3-phenoxymethylpyrrolidine compound
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
MX2013004881A (es) Proceso para la preparacion de n-(bencil)ciclopropanaminas sustituidas mediante hidrogenacion de iminas.
IN2014DN07325A (pl)
MX2015006807A (es) Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.